Carta al Director
La atropina superdiluida al 0,01% frena el aumento de miopía en niños-adolescentes. Un estudio a largo plazo 5 años de evolución: seguridad y eficacia
Superdiluted atropine at 0.01% reduces myopia progression in children and adolescents. A 5-year study of safety and effectiveness
V.M. Asensio-Sánchez
Servicio de Oftalmología, Hospital Clínico Universitario, Valladolid, España
Leído
281
Vecesse ha leído el artículo
92
Total PDF
189
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2024 11 | 1 | 0 | 1 |
| 2024 10 | 3 | 2 | 5 |
| 2024 7 | 1 | 2 | 3 |
| 2024 3 | 1 | 0 | 1 |
| 2024 2 | 1 | 0 | 1 |
| 2023 11 | 1 | 3 | 4 |
| 2023 10 | 4 | 0 | 4 |
| 2023 6 | 4 | 4 | 8 |
| 2023 4 | 2 | 0 | 2 |
| 2023 3 | 2 | 2 | 4 |
| 2023 2 | 1 | 0 | 1 |
| 2022 9 | 1 | 0 | 1 |
| 2022 8 | 1 | 0 | 1 |
| 2022 7 | 1 | 0 | 1 |
| 2022 5 | 1 | 2 | 3 |
| 2022 2 | 1 | 0 | 1 |
| 2021 1 | 1 | 2 | 3 |
| 2021 12 | 2 | 0 | 2 |
| 2021 5 | 1 | 0 | 1 |
| 2021 4 | 9 | 6 | 15 |
| 2021 2 | 1 | 2 | 3 |
| 2020 12 | 3 | 0 | 3 |
| 2020 11 | 1 | 0 | 1 |
| 2020 7 | 3 | 0 | 3 |
| 2020 6 | 1 | 2 | 3 |
| 2020 2 | 5 | 2 | 7 |
| 2020 1 | 6 | 4 | 10 |
| 2019 11 | 2 | 4 | 6 |
| 2019 10 | 1 | 0 | 1 |
| 2019 9 | 23 | 2 | 25 |
| 2019 8 | 1 | 0 | 1 |
| 2019 7 | 3 | 4 | 7 |
| 2019 6 | 1 | 1 | 2 |
| 2019 5 | 7 | 2 | 9 |
| 2019 4 | 8 | 6 | 14 |
| 2019 3 | 84 | 34 | 118 |
| 2018 11 | 0 | 4 | 4 |
| 2018 10 | 0 | 2 | 2 |
Mostrar todo
